These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 22595494)
1. The neurovascular unit and combination treatment strategies for stroke. Zhang L; Zhang ZG; Chopp M Trends Pharmacol Sci; 2012 Aug; 33(8):415-22. PubMed ID: 22595494 [TBL] [Abstract][Full Text] [Related]
2. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator. Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976 [TBL] [Abstract][Full Text] [Related]
3. Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats. Fan X; Lo EH; Wang X Stroke; 2013 Mar; 44(3):745-52. PubMed ID: 23422086 [TBL] [Abstract][Full Text] [Related]
4. Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline. Hess DC; Fagan SC Pharmacotherapy; 2010 Jul; 30(7 Pt 2):55S-61S. PubMed ID: 20575623 [TBL] [Abstract][Full Text] [Related]
5. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator. Lapchak PA; Zivin JA Stroke; 2003 Aug; 34(8):2013-8. PubMed ID: 12855833 [TBL] [Abstract][Full Text] [Related]
6. An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents. Wang Y; Zhang Z; Chow N; Davis TP; Griffin JH; Chopp M; Zlokovic BV Stroke; 2012 Sep; 43(9):2444-9. PubMed ID: 22811462 [TBL] [Abstract][Full Text] [Related]
7. Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator. Lapchak PA; Araujo DM; Song D; Wei J; Purdy R; Zivin JA Stroke; 2002 Jun; 33(6):1665-70. PubMed ID: 12053009 [TBL] [Abstract][Full Text] [Related]
8. Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes. Fan X; Jiang Y; Yu Z; Yuan J; Sun X; Xiang S; Lo EH; Wang X Adv Pharmacol; 2014; 71():391-410. PubMed ID: 25307224 [TBL] [Abstract][Full Text] [Related]
9. Tissue-type plasminogen activator as a therapeutic target in stroke. Gravanis I; Tsirka SE Expert Opin Ther Targets; 2008 Feb; 12(2):159-70. PubMed ID: 18208365 [TBL] [Abstract][Full Text] [Related]
10. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat. Jin R; Xiao AY; Liu S; Wang M; Li G Stroke; 2018 Jul; 49(7):1708-1718. PubMed ID: 29844028 [TBL] [Abstract][Full Text] [Related]
11. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST. Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA; Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855 [TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia, acute ischemic stroke, and thrombolytic therapy. Hafez S; Coucha M; Bruno A; Fagan SC; Ergul A Transl Stroke Res; 2014 Aug; 5(4):442-453. PubMed ID: 24619488 [TBL] [Abstract][Full Text] [Related]
13. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia. Liu W; Hendren J; Qin XJ; Liu KJ Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225 [TBL] [Abstract][Full Text] [Related]
14. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke. Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087 [TBL] [Abstract][Full Text] [Related]
15. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis? Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681 [TBL] [Abstract][Full Text] [Related]